ginkgolide b has been researched along with vitamin k 3 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bazan, NG; DeCoster, MA; Zhu, P | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for ginkgolide b and vitamin k 3
Article | Year |
---|---|
Interplay among platelet-activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival.
Topics: Animals; Antioxidants; Azoles; Cell Death; Cell Survival; Cells, Cultured; Diterpenes; Excitatory Amino Acid Agonists; Free Radicals; Ginkgolides; Hydrogen Peroxide; Isoindoles; L-Lactate Dehydrogenase; Lactones; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitric Oxide Donors; Organoselenium Compounds; Oxidative Stress; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Metabotropic Glutamate; Vitamin K 3 | 2004 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |